HAR §11-156.1-60. Administrative remedies for damaged or seized property

(a) An owner, owner's agent, or person in lawful control of property that was damaged or seized pursuant to section 321-29(d), HRS, may pursue administrative remedies by filing a claim with the department within ninety calendar days from the date of alleged property damage or seizure and in a form and manner as prescribed by the department. (b) A claim shall contain the following information: (1) The claimant's name and contact information; (2) A statement of the facts constituting the alleged damage or seizure, including the physical address where the property was damaged or seized, the date the property was damaged or seized, a description of the damaged or seized property and how the property was damaged or seized; 156.1-28 3625 §11-156.1-60 (3) The dollar amount requested for the damage or seizure with supporting documentation justifying the dollar amount; (4) The claimant's interest in the property with documentation evidencing claimant's lawful control of the damaged or seized property; and (5) The signature of the claimant with an attestation that the information provided in the claim is true and correct to the best of claimant's knowledge. (c) The department shall determine compensation, if any, based on the cost of repairing the property or replacing the property, whichever is less; provided that only the property's useful value at the time of damage or seizure, as determined by the department, shall be considered for compensation. No administrative remedy shall be made for the seizure of de minimus samples or for incidental damages that may be claimed to arise from the property being damaged or seized, including but not limited to, lost income, reputational harm, or emotional distress. (d) A claimant aggrieved by the department's decision pursuant to this section may file a petition for a contested case hearing in accordance with chapter 91, HRS, and chapter 11-1. (e) For the purposes of this section, "claimant" means the person filing a claim for property that was allegedly damaged or seized pursuant to section 321-29(d), HRS. [Eff MAR 20 2026 ] (Auth: HRS §§321-9, 325-13) (Imp: §321-29) 156.1-29 3625= # DEPARTMENT OF HEALTH The repeal of chapter 11-156, Hawaii Administrative Rules, on the Summary Page dated December 15, 2025, occurred on December 15, 2025 and the adoption of chapter 11-156.1, Hawaii Administrative Rules, on the Summary Page dated December 15, 2025, was adopted on December 15, 2025, following a public hearing held on October 22, 2025 after public notice was given in the Honolulu Star Advertiser, West Hawaii Today, Hawaii Tribune Herald, The Garden Island, and The Maui News on September 18, 2025. The repeal of chapter 11-156 and the adoption of chapter 11-156.1 shall take effect ten days after filing with the Office of the Lieutenant Governor. Kenneth S. Fink Kenneth S. Fink, Director Department of Health APPROVED: Josh Green Josh Green Governor State of Hawaii Dated: 3/10/2026 APPROVED AS TO FORM: Kunnell Deputy Attorney General MAR 10 2026 Filed 3625 # EXHIBIT A # HEALTH CARE PROVIDER REPORTABLE DISEASES AND CONDITIONS # CHAPTER 11-156.1, HAR # 12/15/25 Note: Pursuant to §11-156.1-5, HAR, the official list of reportable diseases and conditions shall be the version published on the Department's website. | DISEASE OR CONDITION | TIMEFRAME CATEGORY | | --- | --- | | Amebiasis | Category 3 | | Angiostrongyliasis | Category 2 | | Anthrax | Category 1 | | Arboviral encephalitis and/or meningitis | Category 2 | | Botulism (foodborne or infant) | Category 1 | | Brucellosis (suspected bioterrorism) | Category 1 | | Brucellosis (other than suspected bioterrorism) | Category 2 | | Campylobacteriosis (suspected outbreaks) | Category 2 | | Candida auris | Category 2 | | Chancroid | Category 3 | | Chickenpox (varicella) | Category 3 | | Chikungunya | Category 2 | | Chlamydia (Chlamydia trachomatis) | Category 3 | | Cholera | Category 2 | | Congenital rubella syndrome | Category 3 | | COVID-19 (suspected outbreaks and pediatric deaths) | Category 2 | | Cronobacter species (invasive disease in infants less than twelve months old) | Category 2 | | Cryptosporidiosis | Category 3 | | Cyclosporiasis | Category 3 | | Dengue | Category 2 | | Diphtheria (respiratory) | Category 1 | | Shiga toxin-producing Escherichia coli (STEC) | Category 3 | | Filariasis | Category 3 | | Fish poisoning (ciguatera, scombroid, or hallucinogenic; suspected food establishment-associated) | Category 1 | | Fish poisoning (ciguatera, scombroid, or hallucinogenic; not food establishment-associated) | Category 3 | | Foodborne illness (suspected outbreaks: two or more ill persons having eaten a common food or at a place in common) | Category 2 | | Glanders | Category 1 | | Gonococcal disease (Neisseria gonorrhoeae) | Category 3 | Page 1 of 3 3 6 2 5 _ | DISEASE OR CONDITION | TIMEFRAME CATEGORY | | --- | --- | | *Haemophilus influenzae* (meningitis, bacteremia, epiglottitis, pneumonia, or isolation from a normally sterile site) | Category 2 | | Hansen's disease - Refer to Chapter 11-168, HAR, for reporting requirements | | | Hantavirus disease | Category 2 | | Harmful algal bloom (human disease) | Category 3 | | Hepatitis A | Category 2 | | Hepatitis B (acute) | Category 3 | | Hepatitis B (chronic) | Category 4 | | Hepatitis C (acute) | Category 3 | | Hepatitis C (chronic) | Category 4 | | Hepatitis E | Category 3 | | Hemolytic uremic syndrome (HUS) | Category 3 | | HIV (Human Immunodeficiency Virus) (Stages 0, 1, 2, 3, or stage unknown; Stage 3 shall be reported regardless of previous case report of an earlier stage) | Category 3 | | Influenza (suspected outbreaks and pediatric deaths) | Category 2 | | Influenza-like illness | Category 4 | | Legionellosis | Category 2 | | Leptospirosis | Category 3 | | Listeriosis | Category 3 | | Malaria | Category 2 | | Measles (rubeola) | Category 1 | | Melioidosis | Category 1 | | Meningococcal disease (meningitis, meningococcemia, or isolation from a normally sterile site) | Category 1 | | Middle East Respiratory Syndrome (MERS) | Category 1 | | Mpox | Category 2 | | Mumps | Category 2 | | Nontuberculous mycobacteria (NTM) infection (pulmonary and non-pulmonary) | Category 3 | | Norovirus (NoV) (suspected outbreaks) | Category 2 | | Oropouche virus (congenital and non-congenital) | Category 2 | | Pelvic Inflammatory Disease (PID) | Category 3 | | Pertussis | Category 2 | | Plague | Category 1 | | Poliomyelitis | Category 1 | | Psittacosis | Category 2 | | Q fever | Category 1 | | Rabies | Category 1 | | Respiratory Syncytial Virus (RSV) (suspected outbreaks and pediatric deaths) | Category 2 | | Rubella (German measles) | Category 2 | | *Salmonella* Typhi and Paratyphi | Category 2 | Page 2 of 3 3625 | DISEASE OR CONDITION | TIMEFRAME CATEGORY | | --- | --- | | Salmonellosis (other than typhoid) | Category 3 | | Severe Acute Respiratory Syndrome (SARS) | Category 1 | | Shigellosis | Category 3 | | Smallpox | Category 1 | | Streptococcal disease, Group A (beta hemolytic, invasive disease including Streptococcal Toxic Shock Syndrome, necrotizing fasciitis, or isolation from a normally sterile site, but not including pharyngitis) | Category 3 | | Syphilis | Category 3 | | Tetanus | Category 2 | | Toxoplasmosis | Category 3 | | Trichinosis | Category 3 | | Tuberculosis - Refer to Chapter 11-164.2, HAR, for reporting requirements | | | Tularemia | Category 1 | | Typhus (louse, flea, mite-borne) | Category 3 | | Vibriosis (other than cholera) | Category 3 | | Viral hemorrhagic fevers (filoviruses, e.g. Ebola, Marburg, and arenaviruses, e.g., Lassa, Machupo) | Category 1 | | Yellow fever | Category 2 | | Yersiniosis (other than plague) | Category 3 | | Zika virus (congenital, non-congenital) | Category 2 | Page 3 of 3 3625 # EXHIBIT B # LABORATORY REPORTABLE DISEASES AND CONDITIONS # CHAPTER 11-156.1, HAR # 12/15/25 Note: Pursuant to §11-156.1-5, HAR, the official list of reportable diseases and conditions shall be the version published on the Department's website. | DISEASE/AGENT/TEST | TIMEFRAME CATEGORY | CLINICAL MATERIAL | | --- | --- | --- | | *Angiostrongylus cantonensis* | Category 2 | Upon request | | Arboviral encephalitis and meningitis (Venezuelan equine, Eastern equine, Western equine, California serogroup St. Louis, Powassan, West Nile, Japanese encephalitis virus) | Category 2 | Upon request | | Arenaviruses (Lassa, Marburg) | Category 1a | Required | | *Bacillus anthracis* | Category 1b | Required | | *Bordetella pertussis* | Category 2 | | | *Burkholderia mallei* | Category 1b | Required | | *Burkholderia pseudomallei* | Category 1b | Required | | *Brucella* spp. | Category 2 | Required | | *Brugia malayi* | Category 2 | | | *Brugia timori* | Category 2 | | | *Campylobacter* spp. | Category 2 | | | *Candida auris* | Category 2 | Required | | Carbapenem-resistant *Pseudomonas aeruginosa* (CRPA) | Category 2 | Upon request | | Carbapenem-resistant *Acinetobacter baumannii* (CRAB) | Category 2 | Required | | Carbapenem-resistant Enterobacterales (CRE) | Category 2 | Required | | CD4 T-lymphocyte count and percent | Category 2 | | | Chikungunya virus | Category 2 | Required | | *Chlamydia psittaci* | Category 2 | | | *Chlamydia trachomatis* (report positive and negative results) | Category 2 | | | *Clostridium botulinum* | Category 1a | Upon request | | *Clostridium tetani* | Category 2 | | | *Corynebacterium diphtheriae* | Category 2 | Upon request | | *Cryptosporidium* spp. | Category 2 | | | Cyclosporiasis | Category 2 | | | *Coxiella burnetii* | Category 2 | | | *Cronobacter* species (in infants less than twelve months old) | Category 1b | Upon request | Page 1 of 4 3625 | DISEASE/AGENT/TEST | TIMEFRAME CATEGORY | CLINICAL MATERIAL | | --- | --- | --- | | Dengue virus | Category 2 | Upon request | | Entamoeba histolytica | Category 2 | | | Ehrlichia, other spp. or unspecified | Category 2 | Upon request | | Escherichia coli – shiga toxin producing, including type O157 | Category 2 | Required | | Filoviruses (Ebola, Marburg) | Category 1a | Required | | Francisella tularensis | Category 1b | Upon request | | Giardia lamblia | Category 2 | | | Haemophilus ducreyi | Category 3 | Upon request | | Haemophilus influenzae (from spinal fluid, blood, lung, or other normally sterile site) Report serotype and antimicrobial resistance if available. | Category 2 | Required | | Hantavirus | Category 2 | Upon request | | Hepatitis A virus (IgM positive) - Also report ALT (SGPT) and total bilirubin conducted at the same time. | Category 2 | Required | | Hepatitis B virus (surface antigen positive and negative results and/or anti-core IgM antibody positive and negative results) - Also report ALT (SGPT) and total bilirubin conducted at the same time for all patients who are HBsAg positive. | Category 2 | | | Hepatitis C virus (report positive and negative results) - Also report ALT (SGPT) and total bilirubin conducted at the same time for all patients who are anti-HCV positive. | Category 2 | | | Hepatitis E virus - Also report ALT (SGPT) and total bilirubin conducted at the same time for all patients who are anti-HCE positive. | Category 2 | | | HIV (Human Immunodeficiency Virus) and all HIV viral load tests (report positive and negative results) | Category 2 | | | Influenza virus (report positive, negative and indeterminate results, and other viral isolates obtained through respiratory culture) | Category 2 | | | Legionella pneumophila | Category 2 | Required (isolates only) | | Leptospira interrogans | Category 2 | | | Listeria monocytogenes | Category 2 | Required | | Liver function tests (ALT {SGPT} and total bilirubin) conducted at the same time on a patient who is HAV IgM positive, HbsAg positive, anti-HCV positive, or anti-HCE positive. | Category 2 | | | Lyssavirus spp. (Rabies) | Category 1a | Required | | Measles/Rubeola | Category 2 | Upon request | | Middle East Respiratory Syndrome (MERS) | Category 1a | Required | Page 2 of 4 3625 | DISEASE/AGENT/TEST | TIMEFRAME CATEGORY | CLINICAL MATERIAL | | --- | --- | --- | | Mumps | Category 2 | Upon request | | *Mycobacterium tuberculosis* | Refer to Chapter 11-164.2, HAR | | | *Mycobacterium leprae* (AFB) | Refer to Chapter 11-168, HAR | | | *Neisseria gonorrhoeae* (report positive and negative results, including identification of resistant strains) | Category 2 | Required | | *Neisseria meningitidis* (from spinal fluid, blood, lung, or other normally sterile site), inclusive of gram stain suggestive of *N. meningitidis*. Also report antimicrobial susceptibility when available. | Category 1b | Required | | Nontuberculous mycobacteria (NTM) infection | Category 2 | | | *Non-variola Orthopoxvirus* | Category 2 | Upon request | | Norovirus (NoV) PCR positive | Category 2 | Upon request | | Oropouche virus | Category 2 | Required | | *Plasmodium* spp. | Category 2 | | | Poliovirus | Category 2 | Required | | Respiratory Syncytial Virus (RSV) (report positive, negative, and indeterminate results from viral transport media or universal transport media) | Category 2 | | | *Rickettsia typhi* | Category 2 | | | Rubella (IgM) | Category 2 | Required | | *Salmonella* spp. (including *typhi*) | Category 2 | Required | | SARS-Associated Coronavirus (SARS-CoV) | Category 1a | Required | | SARS-Associated Coronavirus (SARS-CoV-2) (report positive and negative results) | Category 2 | Upon request | | *Shigella* spp. | Category 2 | Required | | Vancomycin-intermediate *Staphylococcus aureus* (VISA) | Category 2 | Upon request | | Vancomycin-resistant *Staphylococcus aureus* (VRSA) | Category 2 | Required | | *Streptococcus pyogenes*, Group A (beta hemolytic, invasive disease including Streptococcal Toxic Shock Syndrome or other normally sterile site, but not including pharyngitis) | Category 2 | | | *Streptococcus pneumoniae* isolated from a normally sterile site, report antimicrobial susceptibility and serotype | Category 2 | Required | | *Toxoplasma gondii* (report positive and negative results) | Category 2 | | | *Treponema pallidum* (report positive and negative results) | Category 2 | Required | | *Trichinella spiralis* | Category 2 | | | West Nile Virus | Category 2 | Upon request | | *Wuchereria bancrofti* | Category 2 | | | Varicella | Category 2 | Upon request | | Variola virus | Category 1a | Required | Page 3 of 4 3625 | DISEASE/AGENT/TEST | TIMEFRAME CATEGORY | CLINICAL MATERIAL | | --- | --- | --- | | *Vibrio* spp. (*cholerae* and non-cholera) | Category 2 | Required | | Yellow fever virus | Category 2 | Required | | *Yersinia pestis* | Category 1b | Required | | *Yersinia* spp. (other than *pestis*) | Category 2 | Required | | Zika virus | Category 2 | Required | Page 4 of 4 3625